Published in J Virol on July 01, 1998
Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol (1999) 2.99
The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A (1999) 1.98
Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J Virol (2000) 1.69
Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol (1998) 1.63
Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol (2001) 1.47
Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol (2001) 1.39
Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol (2001) 1.32
The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol (2003) 1.12
Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein. J Virol (2005) 1.04
Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner. J Virol (2003) 1.03
Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J Virol (2000) 1.02
The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J Virol (2002) 0.98
A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability. J Virol (2004) 0.95
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor. J Virol (2007) 0.91
Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect. J Virol (2005) 0.84
Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells. Proc Natl Acad Sci U S A (2011) 0.82
A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates. Vaccine (2009) 0.79
Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors. PLoS One (2014) 0.77
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Sendai virus contains overlapping genes expressed from a single mRNA. Cell (1983) 4.71
Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell (1988) 3.98
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63
Measles virus P gene codes for two proteins. J Virol (1985) 3.31
HIV accessory proteins: leading roles for the supporting cast. Cell (1995) 2.82
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71
Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol (1990) 2.50
Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev (1996) 2.42
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology (1992) 2.17
Role of vif during packing of the core of HIV-1. Virology (1994) 2.01
The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology (1996) 1.95
The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. J Immunol (1982) 1.94
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94
The immediate downstream codon strongly influences the efficiency of utilization of eukaryotic translation initiation codons. EMBO J (1994) 1.93
Positions +5 and +6 can be major determinants of the efficiency of non-AUG initiation codons for protein synthesis. EMBO J (1994) 1.90
Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J Gen Virol (1997) 1.64
Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol (1998) 1.63
Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells (1998) 1.62
Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology (1997) 1.62
Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59
A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus. J Virol (1993) 1.58
A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology (1997) 1.47
Normal replication of vesicular stomatitis virus without C proteins. Virology (1996) 1.41
The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology (1997) 1.41
Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci (1994) 1.39
Partial characterization of a Sendai virus replication promoter and the rule of six. Virology (1996) 1.35
Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology (1990) 1.30
Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides. Virus Res (1986) 1.24
Sendai viruses with altered P, V, and W protein expression. Virology (1998) 1.15
Association of the Sendai virus C protein with nucleocapsids. Arch Virol (1990) 1.05
Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames. J Virol (1994) 1.01
A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus. J Virol (1994) 0.88
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 29.42
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26
Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol (1993) 10.65
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol (2001) 9.62
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60
Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A (2001) 6.07
Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol (1994) 5.01
Thermostabilization and thermoactivation of thermolabile enzymes by trehalose and its application for the synthesis of full length cDNA. Proc Natl Acad Sci U S A (1998) 4.95
Sendai virus contains overlapping genes expressed from a single mRNA. Cell (1983) 4.71
High-efficiency full-length cDNA cloning by biotinylated CAP trapper. Genomics (1996) 4.41
Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes. Genome Res (2000) 3.78
A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J (1995) 3.63
Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol (1998) 3.62
Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis (1981) 3.62
Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol (1998) 3.60
Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50
N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell (1983) 3.46
Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J (1988) 3.33
Cell-to-cell adherens junction formation and actin filament organization: similarities and differences between non-polarized fibroblasts and polarized epithelial cells. J Cell Sci (1995) 3.27
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci U S A (1991) 3.15
Further characterization of Sendai virus DI-RNAs: a model for their generation. Cell (1977) 3.10
Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell (1981) 3.06
Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol (1999) 2.99
Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci (1997) 2.97
Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J Cell Biol (1996) 2.94
Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology (1992) 2.89
Submembranous junctional plaque proteins include potential tumor suppressor molecules. J Cell Biol (1993) 2.87
The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J (1991) 2.83
Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction. J Cell Biol (1997) 2.82
La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease. J Virol (1984) 2.80
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73
Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics (1995) 2.65
Functional domains of alpha-catenin required for the strong state of cadherin-based cell adhesion. J Cell Biol (1999) 2.59
Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol (1990) 2.50
Repressor activity of Headless/Tcf3 is essential for vertebrate head formation. Nature (2000) 2.49
Mammalian occludin in epithelial cells: its expression and subcellular distribution. Eur J Cell Biol (1997) 2.46
Molecular weight determination of Sendai and Newcastle disease virus RNA. J Virol (1974) 2.45
Meiotic pairing behavior of two free duplications of linkage group I in Caenorhabditis elegans. Mol Gen Genet (1984) 2.39
Modified model for the switch from Sendai virus transcription to replication. J Virol (1989) 2.32
A stuttering model for paramyxovirus P mRNA editing. EMBO J (1990) 2.30
Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol (2000) 2.24
Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci U S A (2000) 2.19
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology (1992) 2.17
Role of Polysulfides in Reduction of Elemental Sulfur by the Hyperthermophilic Archaebacterium Pyrococcus furiosus. Appl Environ Microbiol (1990) 2.16
Structural and signalling molecules come together at tight junctions. Curr Opin Cell Biol (1999) 2.16
Characterization of La Crosse virus small-genome transcripts. J Virol (1984) 2.15
High efficiency selection of full-length cDNA by improved biotinylated cap trapper. DNA Res (1997) 2.11
The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol (1995) 2.10
Primary angiitis of the central nervous system in children: 5 cases. J Rheumatol (2001) 2.08
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Cell (1985) 2.01
Novel models for RNA splicing that involve a small nuclear RNA. Proc Natl Acad Sci U S A (1981) 2.00
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol (1995) 1.98
A novel mechanism for the initiation of Tacaribe arenavirus genome replication. J Virol (1990) 1.98
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94
The ends of La Crosse virus genome and antigenome RNAs within nucleocapsids are base paired. J Virol (1989) 1.93
T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases. J Autoimmun (1996) 1.93
Isolation and characterization of Sendai virus DI-RNAs. Cell (1976) 1.92
Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity (2000) 1.92
Positions +5 and +6 can be major determinants of the efficiency of non-AUG initiation codons for protein synthesis. EMBO J (1994) 1.90
Nontemplated bases at the 5' ends of Tacaribe virus mRNAs. Virology (1990) 1.88
Molecular weight determination of Sendai RNA by dimethyl sulfoxide gradient sedimentation. J Virol (1973) 1.87
Pseudo-templated transcription in prokaryotic and eukaryotic organisms. Genes Dev (1991) 1.83
Unusual transcripts in La Crosse virus-infected cells and the site for nucleocapsid assembly. J Virol (1987) 1.83
Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood (1999) 1.83
Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol (2001) 1.80
Nucleotide sequences of mouse genomic loci including a gene or pseudogene for U6 (4.8S) nuclear RNA. Nucleic Acids Res (1981) 1.78
Scanning independent ribosomal initiation of the Sendai virus X protein. EMBO J (1988) 1.77
Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol (1999) 1.77
Balanced-size and long-size cloning of full-length, cap-trapped cDNAs into vectors of the novel lambda-FLC family allows enhanced gene discovery rate and functional analysis. Genomics (2001) 1.76
Secondary structure of the human T-cell leukemia virus type 1 rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs. J Virol (1990) 1.75
Computer-based methods for the mouse full-length cDNA encyclopedia: real-time sequence clustering for construction of a nonredundant cDNA library. Genome Res (2001) 1.75
Concentric structure of thalamic lesions in acute necrotizing encephalopathy. Neuroradiology (2002) 1.73
Molecular cloning of the 3'-proximal third of Sendai virus genome. Proc Natl Acad Sci U S A (1983) 1.73
Sequence determination of the Sendai virus fusion protein gene. J Gen Virol (1985) 1.73
Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J Virol (2000) 1.69
Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med (2001) 1.67
Tetrameric coiled coil domain of Sendai virus phosphoprotein. Nat Struct Biol (2000) 1.65
The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol (1991) 1.64
Tacaribe arenavirus RNA synthesis in vitro is primer dependent and suggests an unusual model for the initiation of genome replication. J Virol (1992) 1.63
Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol (1998) 1.63
The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site. EMBO J (1991) 1.62
Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology (1997) 1.62
The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol (1993) 1.61
Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci U S A (1997) 1.61
A new 400-kD protein from isolated adherens junctions: its localization at the undercoat of adherens junctions and at microfilament bundles such as stress fibers and circumferential bundles. J Cell Biol (1989) 1.61
Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59